SCHEMBL15567913

SCHEMBL15567913

CC(C)(C)c1ccccc1CCc1nc(Cl)ncc1Cl

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FLT4 P35916 20/20 0.45
▸ KDR P35968 7/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15502390 0.83 FLT4 (0.64) FLT4KDR
SCHEMBL9838551 0.74 ALDH1A1 (0.48) —
SCHEMBL5249724 0.66 ALDH1A1 (0.38) —
SCHEMBL28107473 0.66 ACVRL1 (0.44) FLT4KDR
SCHEMBL30183586 0.66 HTR1A (0.44) —
SCHEMBL6547529 0.66 HTR1A (0.44) —
SCHEMBL7104060 0.65 TDP1 (0.37) —
SCHEMBL29038093 0.65 JUN (0.39) —
SCHEMBL2693816 0.65 ALDH1A1 (0.43) —
SCHEMBL30519922 0.65 JUN (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885291-A1 VEGFR3 INHIBITORS Cancer Therapeutics Crc Pty Limited (AU) 2015-06-24 — — EP disclosed
WO-2014026243-A1 VEGFR3 INHIBITORS CANCER THERAPEUTICS CRC PTY LIMITED (AU) 2014-02-20 — — WO disclosed
Send feedback